2 Stocks to Buy Near Their 52-Week Lows That Could Help You Beat The Market
Equity markets kicked off 2023 on an upbeat note, but some companies seem to have missed the memo and remain southbound. That's the case with biotech giant Amgen (NASDAQ: AMGN) and online dating specialist Match Group (NASDAQ: MTCH) -- both are facing multiple near-term issues that are keeping them close to their 52-week lows.
Digging deeper, though, reveals that Amgen and Match Group both have excellent prospects. Let's consider how these two companies can help deliver market-beating returns over the long run.
Amgen has been dealing with declining sales of some of its key products, causing the company's revenue to grow, if at all, at a pretty modest pace. That's what we saw in 2022, with the company's total revenue climbing by just 1% year over year to $26.3 billion.
Source Fool.com
